BREUIL ROBERT S
Known title: Chief Financial OfficerCIK: 0001241009
Associated companies
Transaction History
| CALC | ▼ Sell | Other | 36,657 | — | 3/23/2023 | View on chart |
| CALC | ▼ Sell | Tax Withholding | 12,677 | $70K | 3/23/2023 | View on chart |
| CALC | ▲ Buy | Option Exercise | 5,000 | — | 3/14/2023 | View on chart |
| CALC | ▼ Sell | Tax Withholding | 1,730 | $1K | 3/14/2023 | View on chart |
| CALC | ▲ Buy | Option Exercise | 121,217 | — | 3/3/2023 | View on chart |
| CALC | ▼ Sell | Tax Withholding | 49,434 | $28K | 3/3/2023 | View on chart |
| CALC | ▲ Buy | Option Exercise | 5,000 | — | 12/12/2022 | View on chart |
| CALC | ▼ Sell | Tax Withholding | 1,729 | $1K | 12/12/2022 | View on chart |
| CALC | ▲ Buy | Option Exercise | 9,938 | — | 12/1/2022 | View on chart |
| CALC | ▼ Sell | Tax Withholding | 3,437 | $2K | 12/1/2022 | View on chart |
| CALC | ▼ Sell | Tax Withholding | 9,726 | $7K | 11/24/2022 | View on chart |
| CALC | ▲ Buy | Option Exercise | 28,125 | — | 11/24/2022 | View on chart |
| CALC | ▼ Sell | Tax Withholding | 1,684 | $2K | 9/23/2022 | View on chart |
| CALC | ▲ Buy | Option Exercise | 5,000 | — | 9/4/2022 | View on chart |
| CALC | ▲ Buy | Option Exercise | 9,937 | — | 8/19/2022 | View on chart |
| CALC | ▼ Sell | Tax Withholding | 3,347 | $3K | 8/19/2022 | View on chart |
| CALC | ▲ Buy | Option Exercise | 5,000 | — | 6/9/2022 | View on chart |
| CALC | ▲ Buy | Option Exercise | 39,750 | — | 5/19/2022 | View on chart |
| CALC | ▼ Sell | Tax Withholding | 16,290 | $15K | 5/19/2022 | View on chart |
| CALC | ▲ Buy | Option Exercise | 5,000 | — | 3/31/2022 | View on chart |
| CALC | ▼ Sell | Open Market | 2,188 | $3K | 3/31/2022 | View on chart |
| CALC | ▲ Buy | Option Exercise | 5,000 | — | 12/4/2021 | View on chart |
| CALC | ▼ Sell | Open Market | 7,283 | $26K | 9/22/2021 | View on chart |
| CALC | ▲ Buy | Option Exercise | 20,000 | — | 9/22/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
CALC files prospectus supplement for $25M ATM offering
CalciMedica has filed a prospectus supplement to conduct an at‑the‑market offering of up to $25 million of common stock. The filing indicates the company is seeking additional capital through a public offering. The stock currently trades near its $0.59 support level, and the neutral RSI suggests no strong momentum at present. The raise could provide funding for operations but may also dilute existing shareholders.
CALC files prospectus supplement for $25M ATM offering. CalciMedica has filed a prospectus supplement to conduct an at‑the‑market offering of up to $25 million of common stock. The filing indicates the company is seeking additional capital through a public offering. The stock currently trades near its $0.59 support level, and the neutral RSI suggests no strong momentum at present. The raise could provide funding for operations but may also dilute existing shareholders.